Suzetrigine for Pain After Vaginal Pelvic Surgery
Treatments studied
Part of Kidney & urinary, Pain, Women’s health & pregnancy clinical trials.
This study tests whether a new pain medication called suzetrigine can reduce the need for opioids (strong painkillers) after vaginal pelvic reconstructive surgery. The goal is to manage post-surgery pain safely with fewer opioids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are having elective transvaginal pelvic reconstructive surgery at UCLA as a same-day discharge or 23-hour stay
- You do not take opioids regularly for chronic pain
- You do not have liver failure or severe kidney disease (ESRD)
- You do not have chronic pain conditions like fibromyalgia, interstitial cystitis, or chronic pelvic pain
- You can safely take acetaminophen and ibuprofen
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.
This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.
This trial tests a new medicine, suzetrigine, for managing acute pain in adults who have broken three or more ribs from a blunt injury. It aims to see if this painkiller works well and is safe for you.
This study tests whether a new pain medication called suzetrigine, when combined with other pain-management strategies, can reduce pain and the need for opioids after total knee replacement surgery. The goal is to help patients recover comfortably while using fewer opioids.
This study tests whether a new pain medication called suzetrigine can help you recover comfortably after a cesarean delivery without needing strong opioid painkillers. You'll receive the study drug and complete follow-up check-ins for two weeks after surgery.
This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.
Hear when a new Postoperative Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.